3. Prevention and treatment of hormone dependent diseases with antiretroviral drugs

摘要

It refers to the use of antiretroviral 11 di (4-ethyne-17 di-hydroxy-17o - (1,1,2,2,2-pentafluoroethane) - estra-4,9-dien-3-ona (I) formula for the treatment or prevention of hormone dependent diseases such as breast cancer; 50 mg per oral administration. It also relates to a compound including an anti rogestin 11 di - (4-acetylene) - 17 di hydroxy-17o - (1,1,2,2-pentafluoro) - estra-4,9-dien-3-ona and an antibiotic.